FTSE All-Share
4.986,34
PKT
-9,01
PKT
-0,18
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
29.10.14 | Standard Chartered neutral | Deutsche Bank AG | |
29.10.14 | Lloyds Banking Group buy | Deutsche Bank AG | |
29.10.14 | BP buy | Citigroup Corp. | |
29.10.14 | Standard Chartered Underweight | HSBC | |
29.10.14 | Standard Chartered Underperform | BNP PARIBAS | |
29.10.14 | Lloyds Banking Group overweight | Morgan Stanley | |
29.10.14 | Standard Chartered Underweight | Morgan Stanley | |
29.10.14 | Standard Chartered Neutral | Goldman Sachs Group Inc. | |
29.10.14 | BP Neutral | Goldman Sachs Group Inc. | |
29.10.14 | BP Neutral | UBS AG | |
29.10.14 | Lloyds Banking Group buy | UBS AG | |
29.10.14 | Standard Chartered buy | UBS AG | |
28.10.14 | Standard Chartered Halten | Independent Research GmbH | |
28.10.14 | Unilever Neutral | Goldman Sachs Group Inc. | |
28.10.14 | Unilever Neutral | Goldman Sachs Group Inc. | |
28.10.14 | BP buy | S&P Capital IQ | |
28.10.14 | Standard Chartered Hold | S&P Capital IQ | |
28.10.14 | GSK Hold | Kepler Cheuvreux | |
28.10.14 | London Stock Exchange (LSE) overweight | Morgan Stanley | |
28.10.14 | HSBC Hold | Deutsche Bank AG | |
27.10.14 | GSK Sell | UBS AG | |
27.10.14 | BAT Halten | Independent Research GmbH | |
27.10.14 | Rio Tinto Outperform | BNP PARIBAS | |
27.10.14 | AstraZeneca buy | UBS AG | |
27.10.14 | Lloyds Banking Group Underperform | Jefferies & Company Inc. | |
27.10.14 | BP Neutral | Goldman Sachs Group Inc. | |
27.10.14 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
27.10.14 | Lloyds Banking Group buy | Deutsche Bank AG | |
27.10.14 | Barclays buy | Deutsche Bank AG | |
24.10.14 | Unilever Equal-Weight | Morgan Stanley | |
24.10.14 | GSK Sell | UBS AG | |
24.10.14 | Unilever Neutral | UBS AG | |
24.10.14 | Barclays buy | UBS AG | |
24.10.14 | Lloyds Banking Group buy | UBS AG | |
24.10.14 | BP Neutral | UBS AG | |
24.10.14 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
23.10.14 | GSK Sell | UBS AG | |
23.10.14 | GSK neutral | Independent Research GmbH | |
23.10.14 | Unilever Sell | S&P Capital IQ | |
23.10.14 | Unilever verkaufen | S&P Capital IQ |